BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28285342)

  • 1. Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine.
    Gorodetska I; Serga S; Lahuta T; Ostapchenko L; Demydov S; Khranovska N; Skachkova O; Inomistova M; Kolesnik O; Svintsitsky V; Tsip N; Peresunko A; Kmit' N; Manzhura O; Rossokha Z; Popova O; Salomakhina H; Kyriachenko S; Kozeretska I
    Fam Cancer; 2017 Oct; 16(4):471-476. PubMed ID: 28285342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
    Van Der Looij M; Szabo C; Besznyak I; Liszka G; Csokay B; Pulay T; Toth J; Devilee P; King MC; Olah E
    Int J Cancer; 2000 Jun; 86(5):737-40. PubMed ID: 10797299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the most frequent BRCA1 mutations in Polish population.
    Brozek I; Cybulska C; Ratajska M; Piatkowska M; Kluska A; Balabas A; Dabrowska M; Nowakowska D; Niwinska A; Pamula-Pilat J; Tecza K; Pekala W; Rembowska J; Nowicka K; Mosor M; Januszkiewicz-Lewandowska D; Rachtan J; Grzybowska E; Nowak J; Steffen J; Limon J
    J Appl Genet; 2011 Aug; 52(3):325-30. PubMed ID: 21503673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
    Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
    Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases.
    Brozek I; Ratajska M; Piatkowska M; Kluska A; Balabas A; Dabrowska M; Nowakowska D; Niwinska A; Rachtan J; Steffen J; Limon J
    Fam Cancer; 2012 Sep; 11(3):351-4. PubMed ID: 22395474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine.
    Gorodetska I; Serga S; Levkovich N; Lahuta T; Ostapchenko L; Demydov S; Anikusko N; Cheshuk V; Smolanka I; Sklyar S; Polenkov S; Boichenko O; Kozeretska I
    Hered Cancer Clin Pract; 2015; 13():19. PubMed ID: 26468334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine.
    Samusieva A; Serga S; Klymenko S; Rybchenko L; Klimuk B; Zakhartseva L; Gorovenko N; Lobanova O; Rossokha Z; Fishchuk L; Levkovich N; Medvedieva N; Popova O; Cheshuk V; Inomistova M; Khranovska N; Skachkova O; Michailovich Y; Ponomarova O; Kozeretska I
    Breast Cancer Res Treat; 2022 Oct; 195(3):453-459. PubMed ID: 35930098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ethnic aspects of hereditary breast cancer in the region of Siberia].
    Cherdyntseva NV; Pisareva LF; Ivanova AA; Panferova YV; Malinovskaya EA; Odintsova IN; Doroshenko AV; Gervas PA; Slonimskaya EM; Shivit-ool AA; Dvornichenko VV; Choinzonov YL
    Vestn Ross Akad Med Nauk; 2014; (11-12):72-9. PubMed ID: 25971130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUTATIONS OF GENES BRCA1 AND BRCA2 IN WOMEN WITH OVARIAN CANCER EXPOSED TO FACTORS OF CHORNOBYL NUCLEAR ACCIDENT.
    Rybchenko LA; Poluben LO; Bychkova GM; Stephanovych GV; Klymenko SV
    Probl Radiac Med Radiobiol; 2019 Dec; 24():455-464. PubMed ID: 31841487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of BRCA1/2 and CHEK2 mutations in ovarian cancer and primary multiple tumors involving the ovaries. Patients of Russian population using biochips].
    Fedorova OE; Liubchenko LN; Paiadini IuG; Kazubskaia TP; Amosenko FA; Gar'kavtseva RF; Zasedatelev AS; Nasedkina TV
    Mol Biol (Mosk); 2007; 41(1):37-42. PubMed ID: 17380889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M; BroZek I; Wysocka B; Haraldsson K; Sandberg T; Johansson U; Sellberg G; Borg A; Limon J
    Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia.
    Tikhomirova L; Sinicka O; Smite D; Eglitis J; Hodgson SV; Stengrevics A
    Fam Cancer; 2005; 4(2):77-84. PubMed ID: 15951956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
    Egeli U; Cecener G; Tunca B; Tasdelen I
    Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genotyping of BRCA1, BRCA2 and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips].
    Nasedkina TV; Gromyko OE; Emel'ianova MA; Ignatova EO; Kazubskaia TP; Portnoĭ SM; Zasedatelev AS; Liubchenko LN
    Mol Biol (Mosk); 2014; 48(2):243-50. PubMed ID: 25850293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
    Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patients.
    Aktas D; Gultekin M; Kabacam S; Alikasifoglu M; Turan AT; Tulunay G; Kose MF; Ortac F; Yüce K; Tunçbilek E; Ayhan A
    Gynecol Oncol; 2010 Oct; 119(1):131-5. PubMed ID: 20638108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of founder mutations in BRCA1 to breast cancer in Belarus.
    Uglanitsa N; Oszurek O; Uglanitsa K; Savonievich E; Lubiński J; Cybulski C; Debniak T; Narod SA; Gronwald J
    Clin Genet; 2010 Oct; 78(4):377-80. PubMed ID: 20507347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia.
    Plakhins G; Irmejs A; Gardovskis A; Subatniece S; Rozite S; Bitina M; Keire G; Purkalne G; Teibe U; Trofimovics G; Miklasevics E; Gardovskis J
    BMC Med Genet; 2011 Oct; 12():147. PubMed ID: 22032251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.